BDNF and Huntington disease: To determine if the acute effects of 0.1 mg/kg fingolimod are distinct at later stages of HD, levels of BDNF and downstream signaling proteins were examined in 7-week-old R6/2 mice, a timepoint when overt motor symptoms are apparent in this HD model [52,61].